Cambridge vaccine expert in $42million partnership to develop 'future-proofed' coronavirus vaccines
08 March 2022Prime Minister Boris Johnson announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42 million (about £32 million) to develop a...